Brief: Allergy Therapeutics Remains Confident In Delivering Revenue Growth In Year To 30 June 2026
19/01/2026 07:30
Jan 19 (Reuters) - Allergy Therapeutics PLC AGY.L: ALLERGY THERAPEUTICS - HALF YEAR TRADING UPDATE ALLERGY THERAPEUTICS PLC - REMAINS CONFIDENT IN DELIVERING REVENUE GROWTH IN YEAR TO 30 JUNE 2026 Source text: ID:nRSS3295Pa Further company coverage: AGY.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allergy Therapeutics
See all newsRCS - Allergy Therapeutics - Allergy Therapeutics to present at EAACI 2026
UK's Allergy Therapeutics H1 revenue rises 7%, operating loss widens
Brief: Allergy Therapeutics H1 Pretax Profit GBP -19.33 Million
Allergy Therapeutics - Interim Results for six months ended 31 Dec 2025
Allergy Therapeutics - PDMR Dealings & Shareholding Update